HPLC purity
Reverse-phase HPLC with UV detection; purity target reported per lot with related-substance reporting on request.
PEG-MGFHPLC ≥ 99%MS confirmed2mg
Vial illustrations reflect supplied lyophilized format. Distribution scope and destination market confirmed before invoicing.
| Compound | PEG-MGF |
|---|---|
| Sequence | YQPPSTNKNTKSQRRKGSTFEERK |
| Form | Lyophilized powder, glass vial |
| Purity target | ≥ 99% by HPLC |
| Vial formats | 2mg |
| Documentation | Batch-document availability confirmed by product, specification and applicable lot |
| Distribution scope | Research use, worldwide |
| Storage | Store lyophilized powder at -20 °C, protected from light and moisture; brief excursions to 2-8 °C are acceptable during shipping. After reconstitution, keep refrigerated at 2-8 °C and use within a short period. Ships with desiccant. |
MOQ & lead time
| Tier | Quantity | Lead time |
|---|---|---|
| OEM lot | 50 kits (500 vials) | 3–7 days |
| Production lot | 500–1,000 vials | 10–14 days |
| OEM repeat | 1,000+ vials | 14–18 days, scheduled |
Supplied as a research-use peptide. Every quote confirms current-batch COA, purity, destination market and buyer track before invoicing.
Overview
About PEG-MGF.
PEG-MGF is a synthetic peptide reproducing the 24-residue mechano growth factor (MGF / IGF-1Ec) C-terminal E-domain, N-terminally conjugated to polyethylene glycol to slow enzymatic degradation and extend circulating half-life versus native MGF. As an IGF-1 splice variant, it is studied in research models for skeletal-muscle repair and satellite-cell activation signaling.
Documentation
Batch documentation support for PEG-MGF lots.
batch-document availability confirmed by product, specification and applicable lot. Distribution scope confirmed before invoicing.
MS identity
Mass spectrometry identity confirmation against the PEG-MGF reference profile.
Lot traceability
Compound prefix and lot serial printed on the vial label and repeated in the document pack and carton.
FAQ
PEG-MGF — frequently asked by B2B buyers.
What is PEG-MGF and what form does Pepti supply?
PEG-MGF is a pegylated version of mechano growth factor (MGF), the alternatively spliced C-terminal E-domain of IGF-1. Pepti supplies it as a lyophilized (freeze-dried) powder in 2 mg vials for laboratory research and private-label programs.
What analytical documentation ships with each lot?
For the applicable lot, Pepti confirms whether available documentation includes a batch-linked COA reporting HPLC purity and mass-spectrometry (MS) identity confirmation. Additional documentation such as batch photos, appearance, and residual-solvent or endotoxin (only if specifically ordered and tested) data can be provided on request for qualifying B2B orders.
What is the molecular weight of PEG-MGF?
The MGF peptide core has a mass of approximately 2867 g/mol, but PEG-MGF is a PEG conjugate, so its total mass depends on the polyethylene glycol chain used and is not a single fixed value. The exact conjugate specification is confirmed per lot on the COA and on RFQ rather than quoted as one universal number.
What are the MOQ, vial size, and private-label options?
Standard supply is 2 mg vials at a minimum order of 50 kits (500 vials). OEM and private-label services, including custom labeling, vial fill, and bulk peptide sourcing, are available; contact us with your target volume for a quotation.
Is PEG-MGF sold for therapeutic use?
No. PEG-MGF is offered strictly as a research-use-only material and is not for consumer or veterinary consumption, diagnostic, or therapeutic use. Buyers are responsible for compliance with applicable regulations in their jurisdiction; note that MGF-class peptides are prohibited in competitive sport under WADA.
Related compounds
Related research peptides.
COA library search
Search public COAs for this product.
The public COA library is being expanded by product and specification. Use the search link below to check current public records for this item.